Adenocarcinoma News and Research

RSS
Adenocarcinoma is cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties.
Detecting tissue-resident memory T cells in solid tumors

Detecting tissue-resident memory T cells in solid tumors

Achieving immune cell checkpoint profiling

Achieving immune cell checkpoint profiling

Diagnosis and treatment of food allergies using a molecular approach

Diagnosis and treatment of food allergies using a molecular approach

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins

Researchers report the circulation of a novel MERS-like coronavirus in Malayan pangolins

Pancreatic cancer rates are rising rapidly among younger women, study confirms

Pancreatic cancer rates are rising rapidly among younger women, study confirms

AI can be a powerful tool to help identify lung nodules on chest X-rays

AI can be a powerful tool to help identify lung nodules on chest X-rays

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

Two million euro ERC Consolidator Grant awarded for finding new therapies against pancreatic cancer

Experts discover mechanism of recruitment for tumor-associated cells in lung adenocarcinoma

Experts discover mechanism of recruitment for tumor-associated cells in lung adenocarcinoma

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Addition of nab-paclitaxel to gemcitabine/cisplatin does not improve overall survival of patients with advanced biliary tract cancers

Addition of nab-paclitaxel to gemcitabine/cisplatin does not improve overall survival of patients with advanced biliary tract cancers

Research reveals the cellular origin of cancer-associated fibroblasts

Research reveals the cellular origin of cancer-associated fibroblasts

Study: Exposure to high doses of micro-sized polyethylene has adverse effects on cells

Study: Exposure to high doses of micro-sized polyethylene has adverse effects on cells

The impact of early life microbial colonization and respiratory diseases on the respiratory microbiome

The impact of early life microbial colonization and respiratory diseases on the respiratory microbiome

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

CAR T cell therapy may enhance the effectiveness of surgery for solid tumors

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

MALAT1 suppression is a hallmark of tissue and peripheral proliferative T cells in COVID-19

Study finds alarming number of older women facing late-stage cervical cancer diagnoses and death

Study finds alarming number of older women facing late-stage cervical cancer diagnoses and death

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

Novel triple immunotherapy combination improves anti-tumor responses in preclinical models of pancreatic cancer

Novel triple immunotherapy combination improves anti-tumor responses in preclinical models of pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.